陈松,程远,廖鹏,等.S100A9真核表达载体pEGFP-N3-S100A9的构建及其对U251细胞生长的影响[J].第三军医大学学报,2012,34(16):1596. Chen Song,Cheng Yuan,Liao Peng,et al.Construction of S100A9 eukaryotic expression vector and its effect on proliferation of glioma cell line U251[J].J Third Mil Med Univ,2012,34(23):1596. [2]姚一搏,许民辉,徐伦山,等.1H-MRS引导辅助伽玛刀治疗20例脑胶质瘤的初步观察[J].第三军医大学学报,2012,34(18):1881. Yao Yibo,Xu Minhui,Xu Lunshan,et al.Preliminary observation on the effect of Gamma Knife treatment for 20 glioma patients with 1H-MRS guidance[J].J Third Mil Med Univ,2012,34(23):1881. [3]姚声涛,唐文渊,郭川.LRIG1诱导人胶质瘤细胞凋亡与表皮生长因子受体基因关系[J].第三军医大学学报,2008,30(02):157. YAO Sheng-tao,TANG Wen-yuan,GUO Chuan.Relationship between LRIG1 induced human glioma apoptosis and EGFR gene[J].J Third Mil Med Univ,2008,30(23):157. [4]王跃红,赵文清,李文玲,等.白介素-24抑制胶质瘤细胞生长的体内外实验研究[J].第三军医大学学报,2008,30(03):229. WANG Yue-hong,ZHAO Wen-qing,LI Wen-ling,et al.Interleukin 24 suppresses the growth of malignant glioma cells in vitro and in vivo[J].J Third Mil Med Univ,2008,30(23):229. [5]张启川,张冬,廖翠薇,等.弥散加权成像对胶质瘤和脑膜瘤的诊断价值[J].第三军医大学学报,2008,30(16):1522. ZHANG Qi-chuan,ZHANG Dong,LIAO Cui-wei,et al.Clinical application of DWI in diagnosis of glioma and meningioma[J].J Third Mil Med Univ,2008,30(23):1522. [6]王博,王毅,陈金华,等.大鼠C6脑胶质瘤生长规律的影像学与病理学观察[J].第三军医大学学报,2008,30(20):1940. WANG Bo,WANG Yi,CHEN Jin-hua,et al.Growth pattern of rat C6 brain gliomas: imaging and histopathologic observation[J].J Third Mil Med Univ,2008,30(23):1940. [7]王舒楠,王毅,李雪,等.大鼠C6脑胶质瘤血管生成的多层螺旋CT灌注成像研究[J].第三军医大学学报,2008,30(20):1944. WANG Shu-nan,WANG Yi,LI Xue,et al.Study on angiogenesis of C6 brain gliomas in rats by MSCT perfusion imaging[J].J Third Mil Med Univ,2008,30(23):1944. [8]冯玉慧,卞修武,郭德玉,等.在人恶性胶质瘤原代培养细胞甲酰化肽受体FPR的表达和功能意义[J].第三军医大学学报,2006,28(24):2440. [9]程迎新,高原,唐文渊,等.垂体瘤转化基因反义寡核苷酸抑制胶质瘤增殖的实验研究[J].第三军医大学学报,2006,28(19):1962. [10]程迎新,唐文渊.恶性胶质瘤患者外周血淋巴细胞基因表达谱的研究[J].第三军医大学学报,2006,28(16):1707.
[2]
卢光明. 动态对比增强MRI的应用与进展[J]. 中华放射学杂志, 2015, 49(6): 406-409. [2]Tofts P S, Brix G, Buckley D L, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols[J]. J Magn Reson Imaging, 1999, 10(3):223-232. [3]Shin J H, Lee H K, Kwun B D, et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results[J]. AJR Am J Roentgenol, 2002, 179(3): 783-789. [4]Hakyemez B, Erdogan C, Ercan I, et al. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging[J]. Clin Radiol, 2005, 60(4): 493-502. [5]Provenzale J M, Mukundan S, Dewhirst M. The role of blood-brain barrier permeability in brain tumor imaging and therapeutics[J]. AJR Am J Roentgenol, 2005, 185(3): 763-767. [6]Provenzale J M, Mukundan S, Barboriak D P. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response[J]. Radiology, 2006, 239(3): 632-649. [7]Veeravagu A, Hou L C, Hsu A R, et al. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model[J]. Neurol Res, 2008, 30(9): 952-959. [8]贾中正, 张军, 汤伟军, 等. DCE-MRI评估脑胶质瘤微血管通透性[J]. 中国医学计算机成像杂志, 2013, 19(4): 293-297. [9]Cha S, Yang L, Johnson G, et al. Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas[J]. AJNR Am J Neuroradiol, 2006, 27(2): 409-417. [10]Falk A, Fahlstrom M, Rostrup E, et al. Discrimination between glioma grades Ⅱ and Ⅲ in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach[J]. Neuroradiology, 2014, 56(12): 1031-1038. [11]Ludemann L, Grieger W, Wurm R, et al. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI[J]. Magn Reson Imaging, 2005, 23(8): 833-841. [12]Choi H S, Kim A H, Ahn S S, et al. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI[J]. Korean J Radiol, 2013, 14(3): 487-492.
